Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Barlev · SciRah

Researcher profile · Semantic Scholar

A. Barlev

Share profile

A. Barlev — researcher profile on SciRah

h-index: 14
Works: 90
Citations: 612

Most-cited papers

Payer Costs for Inpatient Treatment of Pathologic Fracture, Surgery to Bone, and Spinal Cord Compression Among Patients with Multiple Myeloma or Bone Metastasis Secondary to Prostate or Breast Cancer
A. Barlev, Xue Song, B. Ivanov, V. Setty +1 more
2010Journal of Managed Care Pharmacy96 citations Open access
Semantic Scholar
Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer
D. Cella, Zeeshan Butt, H. Kindler, C. Fuchs +3 more
2013Quality of Life Research60 citations
Semantic Scholar
Mean lifetime survival estimates following solid organ transplantation in the US and UK
C. Graham, C. Watson, A. Barlev, M. Stevenson +1 more
2022Journal of Medical Economics51 citations Open access
Semantic Scholar
Assessing analgesic use in patients with advanced cancer: development of a new scale--the Analgesic Quantification Algorithm.
K. Chung, A. Barlev, A. Braun, Y. Qian +1 more
2014Pain medicine (Malden, Mass.)41 citations Open access
Semantic Scholar
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer
G. Hess, A. Barlev, K. Chung, Jerrold W. Hill +1 more
2012Radiation Oncology40 citations Open access
Semantic Scholar
Chronic kidney disease, anemia, and the association between chronic kidney disease-related anemia and activities of daily living in older nursing home residents.
J. Schnelle, D. Osterweil, D. Globe, A. Sciarra +2 more
2009Journal of the American Medical Directors Association39 citations
Semantic Scholar
Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
L. Etemad, Winnie Yang, D. Globe, A. Barlev +1 more
2005Journal of Managed Care Pharmacy37 citations Open access
Semantic Scholar
Clinical and Economic Burden Associated With Stage III to IV Triple-Negative Breast Cancer: A SEER-Medicare Historical Cohort Study in Elderly Women in the United States
K. Schwartz, M. Simon, L. Bylsma, J. Ruterbusch +6 more
2018Cancer28 citations Open access
Semantic Scholar
Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
M. Massoudi, Mark Balk, Hong-Bo Yang, C. Bui +7 more
2017Journal of Medical Economics22 citations Open access
Semantic Scholar
Chronic Kidney Disease and US Healthcare Resource Utilization in a Nationally Representative Sample
M. Alexander, B. Bradbury, R. Kewalramani, A. Barlev +2 more
2008American Journal of Nephrology21 citations
Semantic Scholar
Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021
C. Watson, Dhanalakshmi Thirumalai, A. Barlev, Eddie Jones +2 more
2023Neurological Therapeutics18 citations Open access
Semantic Scholar
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
G. Socié, P. Barba, A. Barlev, Jaime Sanz +14 more
2023Bone Marrow Transplantation18 citations Open access
Semantic Scholar
Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV +) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study
V. Dharnidharka, Dhanalakshmi Thirumalai, U. Jaeger, Wei-Zhi Zhao +10 more
2021Blood14 citations Open access
Semantic Scholar
Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
J. Beebe-Dimmer, J. Ruterbusch, L. Bylsma, C. Gillezeau +6 more
2018Advances in Therapy14 citations Open access
Semantic Scholar
Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data
A. Barlev, V. Lin, A. Katz, Kuo-Lung Hu +2 more
2016Advances in Therapy14 citations Open access
Semantic Scholar
Population preference values for health states in relapsed or refractory B-precursor acute lymphoblastic leukemia in the United Kingdom
M. Aristides, A. Barlev, B. Barber, M. Gijsen +1 more
2015Health and Quality of Life Outcomes13 citations Open access
Semantic Scholar
Healthcare burden and reimbursement of hospitalization during chemotherapy for adults with Ph-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in France: a retrospective chart review
H. Dombret, X. Thomas, P. Chevallier, E. Nivot +4 more
2016Journal of Medical Economics9 citations Open access
Semantic Scholar
Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments
C. Watson, K. Scippa, A. Barlev, K. Kresa-Reahl +1 more
2022Neurological Therapeutics8 citations Open access
Semantic Scholar
Controversy about COOPERATE ABPM Trial Data
S. Maithel, F. Pomposelli, Mark E. Williams, M. Sheahan +63 more
20067 citations Open access
Semantic Scholar
A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen
C. Watson, H. Gadikota, A. Barlev, R. Beckerman
2022Journal of Drug Assessment6 citations Open access
Semantic Scholar
Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study
J. Sanz, J. Storek, G. Socié, Dhanalakshmi Thirumalai +8 more
2021Blood6 citations Open access
Semantic Scholar
Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study
R. Bassan, D. Hoelzer, X. Thomas, P. Montesinos +6 more
2019Advances in Therapy5 citations Open access
Semantic Scholar
Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status
A. Hart, Y. Ahn, C. Watson, M. Skeans +3 more
2021Journal of Medical Economics4 citations Open access
Semantic Scholar
Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients
C. Watson, A. Barlev, J. Worrall, S. Duff +1 more
2020Journal of Drug Assessment4 citations Open access
Semantic Scholar
Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants
C. Watson, Hairong Xu, N. Princic, I. Sruti +1 more
2020Journal of Medical Economics4 citations
Semantic Scholar
Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: a web-based, double-blind survey of EU clinicians
D. Saltman, A. Barlev, D. Seshagiri, Ioannis Katsoulis +2 more
2015BMC Cancer4 citations Open access
Semantic Scholar
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
N. Schultz, N. Shore, S. Chowdhury, L. Klotz +7 more
2018BMC Urology3 citations Open access
Semantic Scholar
Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry
H. Zimmermann, Hairong Xu, A. Barlev, Yang Zhang +3 more
2019Blood2 citations Open access
Semantic Scholar
A Systematic Literature Review of Real-World Evidence in Post-Transplant Lymphoproliferative Disorder
Hairong Xu, A. Forsythe, A. Barlev, N. Rashid +1 more
2018Blood2 citations
Semantic Scholar
Younger Patients Are Impacted By Post-Transplant Lymphoproliferative Disorder: Findings from a Systematic Literature Review of Real-World Evidence
C. Watson, Hairong Xu, A. Forsythe, S. A. Garib +1 more
2018Blood2 citations Open access
Semantic Scholar
Treatment patterns and associated adverse events among patients with metastatic triple-negative breast cancer.
V. Kaklamani, N. Schultz, D. Irwin, N. Fulcher +6 more
20172 citations
Semantic Scholar
Real-world study of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or abiraterone acetate plus prednisone (AA+P): Patient characteristics and treatment persistence.
K. Moses, D. Penson, N. Schultz, Fei Shi +4 more
20172 citations
Semantic Scholar
Hospital admissions (HA) among chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients newly treated with enzalutamide (ENZA) or abiraterone (ABI).
R. Quek, A. Gilligan, Shia T. Kent, C. Gregory +5 more
20172 citations
Semantic Scholar
3037 Development of the Analgesic Quantification Algorithm (AQA): a new scale to assess changes in analgesic use
K. Chung, A. Barlev, A. Braun, Y. Qian +1 more
20092 citations
Semantic Scholar
Clinical Outcomes Associated with Conversion from Epoetin alfa to Darbepoetin alfa in Hospitalized Hemodialysis Patients
E. Sarac, Anand Chikyarappa, Brian Sabol, D. Gemmel +3 more
2007American Journal of Nephrology2 citations
Semantic Scholar
PHM1 EFFECTIVENESS OF EPOETIN ALFA IN REDUCING THE NUMBER OF BLOOD TRANSFUSIONS IN CRITICALLY ILL SICU PATIENTS
Vw Luh, A. Barlev, J. Kern
20052 citations Open access
Semantic Scholar
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
S. Chaganti, A. Barlev, S. Caillard, S. Choquet +8 more
2023Advances in Therapy1 citations Open access
Semantic Scholar
P42 Comparison of Estimation Methods for Single-Arm Trials in Rare Diseases with Historical Control Groups
A. Barlev, M. Brookhart, P. Xun, D. Thirumalai +2 more
2022Value in Health1 citations Open access
Semantic Scholar
High Healthcare Resource Utilization and Cost for PTLD Patients Following Kidney Transplants
A. Hart, Y. Ahn, C. Watson, M. Skeans +3 more
20201 citations Open access
Semantic Scholar
Risk of Patients Developing Post-Transplant Lymphoproliferative Disorder within the First Year after an Allogeneic Hemopoietic Stem Cell Transplant, 2011 to 2016: A US Claims Database Analysis
A. Barlev, Hairong Xu, N. Fulcher, C. Watson +2 more
2018Blood1 citations
Semantic Scholar
Treatment Patterns for Patients with Post-Transplant Lymphoproliferative Disorder Who Fail Rituximab after Allogeneic Hematopoietic Stem Cell Transplantation: Findings from a Systematic Literature Review
Hairong Xu, C. Watson, S. A. Garib, A. Forsythe +1 more
2018Blood1 citations
Semantic Scholar
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
N. Schultz, N. Shore, S. Chowdhury, L. Klotz +7 more
2018BMC Urology1 citations Open access
Semantic Scholar
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer
G. Hess, A. Barlev, K. Chung, Jerrold W. Hill +1 more
2012Radiation Oncology1 citations Open access
Semantic Scholar
79 HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH SKELETAL RELATED EVENTS IN PROSTATE CANCER PATIENTS WITH BONE METASTASES
T. Delea, A. Barlev, M. Hagiwara, J. Pinzone +1 more
20111 citations
Semantic Scholar
Response to the Letter by Dr. Crecelius
J. Schnelle, D. Osterweil, A. Sciarra, P. Audhya +1 more
20091 citations
Semantic Scholar
PNP16: THE COMPARISON OF DIFFERENT METHODS FOR DETERMINING THE IMPACT OF MIGRAINE PROPHYLAXIS ON COSTS
A. Barlev, E. Wu, W. Yu, Ka Johnson
20031 citations Open access
Semantic Scholar
PCR163 Work Productivity Impairment Among Individuals with Progressive Multiple Sclerosis
E. Heidari, C Peter N Watson, D. Thirumalai, A. Barlev +3 more
2023Value in Health0 citations Open access
Semantic Scholar
RWD50 Characteristics of Health Insurance Coverage in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States
J. Chen, C Peter N Watson, D. Thirumalai, A. Barlev +3 more
2023Value in Health0 citations
Semantic Scholar
PCR215 Work Productivity Impairment By Type of Worker in Active and Nonactive Progressive Multiple Sclerosis
E. Heidari, C Peter N Watson, D. Thirumalai, A. Barlev +3 more
2023Value in Health0 citations Open access
Semantic Scholar
PCR115 Adherence to Disease-Modifying Treatments in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States
J. Chen, C Peter N Watson, D. Thirumalai, A. Barlev +3 more
2023Value in Health0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Watson×12
Invite
C. Watson — researcher profile on SciRah
S. Flanders×8
Invite
S. Flanders — researcher profile on SciRah
N. Schultz×7
Invite
N. Schultz — researcher profile on SciRah
K. Chung×6
Invite
K. Chung — researcher profile on SciRah

Dhanalakshmi Thirumalai

×6

Invite

Dhanalakshmi Thirumalai — researcher profile on SciRah

K. Kresa-Reahl×6

Invite

K. Kresa-Reahl — researcher profile on SciRah

Invite

Hairong Xu — researcher profile on SciRah

Bruce A. Brown×5

Invite

Bruce A. Brown — researcher profile on SciRah

S. Bogdanovich×5

Invite

S. Bogdanovich — researcher profile on SciRah

Invite

B. Barber — researcher profile on SciRah

D. Thirumalai×5

Invite

D. Thirumalai — researcher profile on SciRah

Invite

D. Globe — researcher profile on SciRah